局部氨甲环酸在乳房再造中的应用:双盲随机对照试验
这项配对双盲随机对照试验纳入53例(106侧乳房)双侧乳房切除并即刻假体再造患者,每例一侧乳房随机接受3 g氨甲环酸(100 cc)浸泡5分钟,对侧接受100 cc生理盐水。结果显示氨甲环酸侧平均引流量减少30.5%,引流管拔除早1.4天,并发症3例(5.67%)对15例(28.3%)(OR 0.1920;P=0.0129)。
要点
- 氨甲环酸侧平均引流量较对照侧减少30.5%(范围-83.6%至26.6%)。
- 氨甲环酸侧引流管拔除较对照侧早1.4天(范围0至4天)。
- 氨甲环酸组并发症3例(5.67%)对对照组15例(28.3%)(OR 0.1920;P=0.0129)。
核心结论
- 在假体置入前用3%局部氨甲环酸浸泡乳房切除床可减少引流量并减少并发症。
- 作者认为局部应用氨甲环酸是减少假体乳房再造并发症的一种选择。
研究设计与样本
- 配对、双盲、随机对照试验,纳入接受双侧乳房切除并即刻直接置入假体再造的患者。
- 每例患者一侧乳房随机接受3 g氨甲环酸(100 cc),对侧接受100 cc生理盐水,盲法溶液在假体置入前浸泡乳房切除床5分钟。
- 共纳入53例符合条件患者,代表106侧乳房;所有患者均接受双侧保留乳头乳房切除术。
- 随机化后氨甲环酸置于右乳者30例(56.6%)。
主要发现
- 局部氨甲环酸使平均引流量减少30.5%(范围-83.6%至26.6%)。
- 氨甲环酸侧引流管较对照侧早1.4天(范围0至4天)符合拔除条件。
- 氨甲环酸组并发症3例(5.67%),对照组15例(28.3%)(OR 0.1920;P=0.0129)。
- 手术血肿:氨甲环酸组0例(0%),对照组3例(5.7%)(OR 0.1348;P=0.18)。
关键数值与推荐
- 局部氨甲环酸用法:3 g氨甲环酸(100 cc)浸泡乳房切除床5分钟。
- 证据等级:治疗性,I级。
临床怎么用
- 作者认为局部应用氨甲环酸是减少假体乳房再造并发症的一种选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Excess fluid accumulation (seroma/hematoma) around the breast implant after reconstruction can lead to significant complications. Topical administration of tranexamic acid (TXA) may reduce fluid accumulation and reduce postoperative complications. This trial aims to investigate whether TXA-treated mastectomy pockets will exhibit less postoperative fluid production and complications. METHODS: This paired, double-blind, randomized, controlled trial enrolled patients undergoing bilateral mastectomies with immediate direct-to-implant reconstruction. In each patient, one breast was randomized to receive 3 g of TXA (100 cc), and the other received 100 cc of normal saline. The blinded solutions were soaked in the mastectomy pocket for 5 minutes before implant placement. Postoperatively, daily drain outputs, complications, and baseline demographics were recorded. RESULTS: Fifty-three eligible patients, representing 106 breasts, were enrolled. All patients underwent bilateral nipple-sparing mastectomies. After randomization, TXA was placed in the right breast in 30 patients (56.6%). The use of topical TXA resulted in a mean drain output reduction of 30.5% (range, -83.6% to 26.6%). Drains on the TXA-treated breast were eligible for removal 1.4 days (range, 0 to 4 days) sooner than the control side. The TXA-treated group had three complications (5.67%) versus 15 (28.3%) in the control group (OR, 0.1920; P = 0.0129). Specifically, for operative hematomas, the TXA group had none (0%), versus three in the control group (5.7%) (OR, 0.1348; P = 0.18). CONCLUSIONS: Soaking the mastectomy bed with 3% topical TXA before implant insertion leads to a decrease in drain output and a decrease in complications. Topical administration of TXA represents an option to decrease complications in alloplastic breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.
引用
- Safran T, Vorstenbosch J, Viezel-Mathieu A, et al. Topical Tranexamic Acid in Breast Reconstruction: A Double-Blind Randomized Controlled Trial. Plast Reconstr Surg. 2023. PMID: 36827482. doi:10.1097/PRS.0000000000010322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。